Notwithstanding travel and work commitments, I’ve finally managed to do some follow up work on SAV and its deal with Emefcy.
After putting my feelers out with my brokers, I actually spoke to one of the brokers who attended a presentation by the SAV team. To say he came away from the presentation extremely impressed would be an understatement.
He stated that the team was VERY professional – above and beyond what you see not only with most companies this size but with most publicly listed companies, period. He reckons the technology looks top notch. It’s in a hot space (which will continue to be hot for a long time), the team has done it before in a similar space so they have the cred and the proven ability to perform and the US guys have taken companies to market caps in the billions and believe they’re on a real winner with SAV. Monies will be raised in the next few months & the company will relist hopefully be December.
I’ll keep a close eye on this and keep you informed with any updates.
In the meantime, check out my other post with some more technical work on Emefcy’s technology and how it seemingly ticks the right boxes on so many levels.
SAV Price at posting:
0.3¢ Sentiment: Buy Disclosure: Not Held
